Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Artemis Therapeutics, Inc. | exhibit_31-1.htm |
| 10-Q - 10-Q - Artemis Therapeutics, Inc. | zk1619176.htm |
EXHIBIT 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER
PURSUANT TO U.S.C. SEC. 1350
The undersigned officer of New York Global Innovations Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge:
| (i) |
That the Quarterly Report for the fiscal quarter ended September 30, 2016 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
| (ii) |
The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
Date: November 14, 2016
|
/s/ Chanan Morris
|
|
|
|
By: Chanan Morris, Chairman of the Board, Chief Financial Officer
(Principal Executive Officer, Principal Financial and Accounting Officer)
|
|
